Current perspectives on Mohs micrographic surgery for melanoma

Derek Beaulieu, Ramin Fathi, Divya Srivastava, Rajiv I Nijhawan

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Mohs micrographic surgery (MMS), a specialized surgical excision technique used primarily in the treatment of skin cancers, is tissue sparing and provides optimal margin control through evaluation of 100% of both the peripheral and deep margin. The use of MMS for the treatment of malignant melanoma (MM) and melanoma in situ (MIS) has been slow in gaining the same widespread acceptance that it has for keratinocyte carcinomas despite its cost-effectiveness and the growing body of evidence demonstrating similar or improved cure rates to standard wide local excision. However, modern advances in immunohistochemical staining have continued to greatly enhance the ability of Mohs surgeons to interpret MMS frozen sections of melanoma specimens – the primary concern of most opponents of MMS for melanoma. These advances, coupled with an increased recognition by professional organizations of the utility of MMS in treating MM and MIS, have led to a rise in the use of MMS for melanoma in recent years. Given the expanding role of MMS in the treatment of cutaneous melanoma, this manuscript will describe how MMS is performed, discuss the rationale and current evidence regarding the use of MMS for MM and MIS, review the immunohistochemical stains currently available for use in MMS, and consider special situations and future directions in this area of growing interest.

Original languageEnglish (US)
Pages (from-to)309-320
Number of pages12
JournalClinical, Cosmetic and Investigational Dermatology
Volume11
DOIs
StatePublished - May 30 2018

Fingerprint

Mohs Surgery
Melanoma
Frozen Sections
Skin Neoplasms
Keratinocytes
Cost-Benefit Analysis
Coloring Agents
Therapeutics

Keywords

  • Evidence
  • Immunohistochemical stains
  • Melanoma
  • Melanoma in situ
  • Mohs micrographic surgery
  • Review

ASJC Scopus subject areas

  • Dermatology

Cite this

Current perspectives on Mohs micrographic surgery for melanoma. / Beaulieu, Derek; Fathi, Ramin; Srivastava, Divya; Nijhawan, Rajiv I.

In: Clinical, Cosmetic and Investigational Dermatology, Vol. 11, 30.05.2018, p. 309-320.

Research output: Contribution to journalReview article

@article{da6294c7ea57460ebf9ce800f05f151d,
title = "Current perspectives on Mohs micrographic surgery for melanoma",
abstract = "Mohs micrographic surgery (MMS), a specialized surgical excision technique used primarily in the treatment of skin cancers, is tissue sparing and provides optimal margin control through evaluation of 100{\%} of both the peripheral and deep margin. The use of MMS for the treatment of malignant melanoma (MM) and melanoma in situ (MIS) has been slow in gaining the same widespread acceptance that it has for keratinocyte carcinomas despite its cost-effectiveness and the growing body of evidence demonstrating similar or improved cure rates to standard wide local excision. However, modern advances in immunohistochemical staining have continued to greatly enhance the ability of Mohs surgeons to interpret MMS frozen sections of melanoma specimens – the primary concern of most opponents of MMS for melanoma. These advances, coupled with an increased recognition by professional organizations of the utility of MMS in treating MM and MIS, have led to a rise in the use of MMS for melanoma in recent years. Given the expanding role of MMS in the treatment of cutaneous melanoma, this manuscript will describe how MMS is performed, discuss the rationale and current evidence regarding the use of MMS for MM and MIS, review the immunohistochemical stains currently available for use in MMS, and consider special situations and future directions in this area of growing interest.",
keywords = "Evidence, Immunohistochemical stains, Melanoma, Melanoma in situ, Mohs micrographic surgery, Review",
author = "Derek Beaulieu and Ramin Fathi and Divya Srivastava and Nijhawan, {Rajiv I}",
year = "2018",
month = "5",
day = "30",
doi = "10.2147/CCID.S137513",
language = "English (US)",
volume = "11",
pages = "309--320",
journal = "Clinical, Cosmetic and Investigational Dermatology",
issn = "1178-7015",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Current perspectives on Mohs micrographic surgery for melanoma

AU - Beaulieu, Derek

AU - Fathi, Ramin

AU - Srivastava, Divya

AU - Nijhawan, Rajiv I

PY - 2018/5/30

Y1 - 2018/5/30

N2 - Mohs micrographic surgery (MMS), a specialized surgical excision technique used primarily in the treatment of skin cancers, is tissue sparing and provides optimal margin control through evaluation of 100% of both the peripheral and deep margin. The use of MMS for the treatment of malignant melanoma (MM) and melanoma in situ (MIS) has been slow in gaining the same widespread acceptance that it has for keratinocyte carcinomas despite its cost-effectiveness and the growing body of evidence demonstrating similar or improved cure rates to standard wide local excision. However, modern advances in immunohistochemical staining have continued to greatly enhance the ability of Mohs surgeons to interpret MMS frozen sections of melanoma specimens – the primary concern of most opponents of MMS for melanoma. These advances, coupled with an increased recognition by professional organizations of the utility of MMS in treating MM and MIS, have led to a rise in the use of MMS for melanoma in recent years. Given the expanding role of MMS in the treatment of cutaneous melanoma, this manuscript will describe how MMS is performed, discuss the rationale and current evidence regarding the use of MMS for MM and MIS, review the immunohistochemical stains currently available for use in MMS, and consider special situations and future directions in this area of growing interest.

AB - Mohs micrographic surgery (MMS), a specialized surgical excision technique used primarily in the treatment of skin cancers, is tissue sparing and provides optimal margin control through evaluation of 100% of both the peripheral and deep margin. The use of MMS for the treatment of malignant melanoma (MM) and melanoma in situ (MIS) has been slow in gaining the same widespread acceptance that it has for keratinocyte carcinomas despite its cost-effectiveness and the growing body of evidence demonstrating similar or improved cure rates to standard wide local excision. However, modern advances in immunohistochemical staining have continued to greatly enhance the ability of Mohs surgeons to interpret MMS frozen sections of melanoma specimens – the primary concern of most opponents of MMS for melanoma. These advances, coupled with an increased recognition by professional organizations of the utility of MMS in treating MM and MIS, have led to a rise in the use of MMS for melanoma in recent years. Given the expanding role of MMS in the treatment of cutaneous melanoma, this manuscript will describe how MMS is performed, discuss the rationale and current evidence regarding the use of MMS for MM and MIS, review the immunohistochemical stains currently available for use in MMS, and consider special situations and future directions in this area of growing interest.

KW - Evidence

KW - Immunohistochemical stains

KW - Melanoma

KW - Melanoma in situ

KW - Mohs micrographic surgery

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=85057085462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057085462&partnerID=8YFLogxK

U2 - 10.2147/CCID.S137513

DO - 10.2147/CCID.S137513

M3 - Review article

C2 - 29950878

AN - SCOPUS:85057085462

VL - 11

SP - 309

EP - 320

JO - Clinical, Cosmetic and Investigational Dermatology

JF - Clinical, Cosmetic and Investigational Dermatology

SN - 1178-7015

ER -